Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Oncoclínicas has Net Profit of R$149 million (162% higher vs 3Q22) and Gross Revenue of R$1.5 billion in the third quarter

Published

on

oncoclinicas-has-net-profit-of-r$149-million-(162%-higher-vs-3q22)-and-gross-revenue-of-r$1.5-billion-in-the-third-quarter

Operating Cash Generation was R$322 million, a record for the company’s third quarter

SÃO PAULO, Nov. 17, 2023 /PRNewswire/ — Oncoclínicas & Co. (B3: ONCO3) reported a 23.4% increase in its gross revenue in the third quarter of 2023, reaching R$1.5 billion, another record for the company. The performance, which is entirely organic, is mainly the result of the increase in the number of treatments provided to patients (+14.4%), reflecting the resilience of the cancer treatment segment combined with the gain in market share. In the nine-month period ended in September 30th, the gross revenue reached R$4.4 billion. The gross profit totaled R$495.8 million in 3Q23, up 21.7% on 3Q22 and with a margin of 35.4% higher than that reported last year (35.0%), which demonstrates continued gains in operational efficiency.

“We continued to expand at over 20% a year even without any new acquisitions in the period. 2023 has been a year in which we have keep on delivering all the synergies and value creation initiatives that we said we would deliver over the last two years. All this in line with our thesis and business model that puts the patient at the center of everything”, highlights Bruno Ferrari, founder and CEO of Oncoclínicas & Co.

EBITDA Ex-PILP (excluding only the non-cash effect of the long-term incentive plan) totaled R$269.1 million in the 3Q23, 39.2% higher than the R$193.2 million reported in the 3Q22, and with a margin of 19.2%, 2.6 percentage points higher than in the same quarter of the previous year. The EBITDA improvement continues to reflect progress in the integration process of the acquired units, with the capture of efficiency gains and synergies. For the first nine months of the year (9M23), the EBITDA Ex-PILP already totaled R$814.2 million, with a margin of 20.1%.

This was also the fifth consecutive quarter of net profit, which reached R$149.3 million, more than 2.6 times that one reported in the same period of 2022. The net profit for the first nine months of the year totaled R$225.5 million. Operating cash flow (OCF) totaled R$322 million, reflecting another quarter of solid operating performance, active management of the revenue cycle, inventories and intense work with the suppliers. For the 9M23 period, the OCF / EBITDA conversion is close to 40%. Even after the debt service and all the maintenance Capex, the cash generation was R$87 million in 3Q23.

The number of treatments provided to patients increased by 14.4% in 3Q23 compared to 3Q22, reaching a total of 161.8 thousand. The volume of treatments over the last 12 months totals around 615 thousand.

According to Rodrigo Medeiros, Executive Vice-President of Oncoclínicas & Co., “Despite a scenario that is still adverse for the health sector, with our partners – the health plans and operators – recovering from record claims rates, we have demonstrated that it is possible to deliver superior results by seeking more efficiency in-house, in operations and in optimizing the working capital cycle”.

Cristiano Camargo, CFO and Director of Investor Relations, adds: “We continue to pay close attention to two important value levers: (I) moving forward with internal corporate reorganizations to optimize the effective tax rate with an impact on net income and (II) optimizing our working capital cycle, with an effect on the conversion of EBITDA into operating cash flow. We have been able to consistently deliver both”.

Subsequent events in the quarter included investments and partnerships such as: strategic agreement with Unimed Recife to coordinate the oncology care line for the next 30 years; acquisition of a further 25% shareholding in the partnership with Unimed Nacional in the oncology units in São Paulo, Brasília and Salvador, now reaching 75%; approval by CADE of the 60-years agreement with Grupo Santa for joint operations in Brasília; and inauguration of the first Oncoclínicas Cancer Center in partnership with Dana-Farber, the first operation outside the United States to be certified as an International Collaborative Member of the Dana-Farber Cancer Institute.

The information is contained in the data released to the market on Monday (11/13) by

Advertisement

Oncoclínicas (https://ri.grupooncoclinicas.com/).

View original content:https://www.prnewswire.co.uk/news-releases/oncoclinicas-has-net-profit-of-r149-million-162-higher-vs-3q22-and-gross-revenue-of-r1-5-billion-in-the-third-quarter-301992184.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Markel Group reports 2024 third quarter and nine-months results

Published

on

markel-group-reports-2024-third-quarter-and-nine-months-results

RICHMOND, Va., Oct. 30, 2024 /PRNewswire/ — Markel Group Inc. (NYSE: MKL) today reported its financial results for the third quarter of 2024. The Company also announced today it filed its Form 10-Q for the quarter ended September 30, 2024 with the Securities and Exchange Commission. Markel Group aspires to build one of the world’s great companies and deploys three financial engines in pursuit of this goal: Insurance, Investments and Markel Ventures.

“We’ve consistently emphasized the value of our family of businesses that have found a home under the Markel Group umbrella. The results of 2024 so far underscore that benefit. Many of our businesses performed exceptionally, others made solid improvements where there was room for improvement, and a few faced slowdowns or challenges,” said Tom Gayner, Chief Executive Officer. “Overall, we achieved strong results, and we’re confident in our long-term ability for that to continue to be the case.”

The following table presents summary financial data, by engine, for the quarters and nine months ended September 30, 2024 and 2023.

Quarter Ended September 30,

Nine Months Ended September 30,

(dollars in thousands, except per share amounts)

2024

2023

2024

2023

Advertisement

Operating revenues:

Insurance

$    2,185,758

$        2,208,352

$    6,519,744

$        6,327,165

Investments:

Net investment income

233,384

191,015

Advertisement

671,042

518,536

Net investment gains (losses)

917,530

(265,917)

1,689,794

591,173

Other

14,971

(5,033)

Advertisement

45,174

(13,791)

Total Investments

1,165,885

(79,935)

2,406,010

1,095,918

Markel Ventures

1,259,621

1,246,769

Advertisement

3,854,008

3,738,028

Total operating revenues

$    4,611,264

$        3,375,186

$  12,779,762

$      11,161,111

Operating income:

Insurance (1)

$        145,273

Advertisement

$             69,870

$        458,023

$           444,571

Investments:

Net investment income

233,384

191,015

671,042

518,536

Net investment gains (losses)

Advertisement

917,530

(265,917)

1,689,794

591,173

Other

14,971

(5,033)

45,174

(13,791)

Total Investments

Advertisement

1,165,885

(79,935)

2,406,010

1,095,918

Markel Ventures

106,627

130,420

388,040

392,648

Consolidated segment operating income (2)

Advertisement

1,417,785

120,355

3,252,073

1,933,137

Amortization of acquired intangible assets

(46,459)

(47,545)

(134,981)

(136,367)

Total operating income

Advertisement

$    1,371,326

$             72,810

$    3,117,092

$        1,796,770

Comprehensive income (loss) to shareholders

$    1,329,458

$         (107,500)

$    2,482,199

$        1,103,414

Diluted net income per common share

Advertisement

$           66.25

$                3.14

$         160.42

$               90.69

Combined ratio

96.4 %

99.1 %

95.1 %

95.4 %

(1)     See “Supplemental Financial Information” for the components of our Insurance engine operating income.

Advertisement

(2)     See “Non-GAAP Financial Measures” for additional information on this non-GAAP measure.

 

Highlights of results from the quarter and nine months:

  • Operating revenue growth of 37% and 15% for the quarter and nine months ended September 30, 2024, respectively, as well as significant growth in operating income, was driven by our Investments engine.
  • Our Investments engine benefited from more favorable market value movements within our equity portfolio in 2024 compared to 2023. Generally accepted accounting principles (GAAP) require that we include unrealized gains and losses on equity securities in net income. This may lead to short-term volatility in revenues and operating income that temporarily obscures our underlying operating performance.
  • Net investment income within our Investments engine increased 22% and 29% for the quarter and nine months ended September 30, 2024, respectively, reflecting higher interest rates and increased investment holdings in 2024 compared to 2023.
  • Our Insurance engine benefited from strong performance by our international operations, the favorable impact of underwriting actions by our U.S. operations and continued growth in our program services business in 2024, while the performance of our Reinsurance segment was negatively impacted by elevated levels of losses on certain product lines.
  • Underwriting results for the quarter and nine months ended September 30, 2024 included $62 million of net losses and loss adjustment expenses attributed to Hurricane Helene, or three points and one point on the quarter-to-date and year-to-date consolidated combined ratio, respectively.
  • Our Markel Ventures engine grew operating revenues in 2024 driven by our consumer and building products businesses, while operating income decreased due in part to lower operating margins at certain of our businesses.

We believe our financial performance is most meaningfully measured over longer periods of time, which tends to mitigate the effects of short-term volatility and also aligns with the long-term perspective we apply to operating our businesses and making investment decisions. The following table presents a long-term view of our performance.

Nine Months
Ended
September 30,

Years Ended December 31,

(dollars in thousands)

2024

2023

2022

2021

Advertisement

2020

Operating income (loss):

Insurance (1)

$     458,023

$     348,145

$     928,709

$     718,800

$     136,985

Investments (2)

2,406,010

Advertisement

2,241,419

(1,167,548)

2,353,124

989,564

Markel Ventures

388,040

519,878

404,281

330,120

306,650

Advertisement

Consolidated segment operating income (3)

3,252,073

3,109,442

165,442

3,402,044

1,433,199

Amortization and impairment

(134,981)

(180,614)

(258,778)

Advertisement

(160,539)

(159,315)

Total operating income (loss)

$  3,117,092

$  2,928,828

$      (93,336)

$  3,241,505

$  1,273,884

Net investment gains (losses) (2)

$  1,689,794

Advertisement

$  1,524,054

$ (1,595,733)

$  1,978,534

$     617,979

Compound annual growth rate in closing stock price
per share from December 31, 2019 to September 30, 2024

7 %

(1)

See “Supplemental Financial Information” for the components of our Insurance engine operating income.

(2)

Investments engine operating income includes net investment gains (losses), which are primarily comprised of unrealized gains and losses on equity securities.

Advertisement

(3)

See “Non-GAAP Financial Measures” for additional information on this non-GAAP measure.

 

* * * * * * * *

A copy of our Form 10-Q is available on our website at mklgroup.com, under Investor Relations-Financials, or on the SEC website at www.sec.gov. Readers are urged to review the Form 10-Q for a more complete discussion of our financial performance. Our quarterly conference call, which will involve discussion of our financial results and business developments and may include forward-looking information, will be held Thursday, October 31, 2024, beginning at 9:30 a.m. (Eastern Time). Investors, analysts and the general public may listen to the call via live webcast at ir.mklgroup.com. The call may be accessed telephonically by dialing (800) 715-9871 in the U.S., or (646) 307-1963 internationally, and providing Conference ID: 4614568. A replay of the call will be available on our website approximately one hour after the conclusion of the call. Any person needing additional information can contact Markel Group’s Investor Relations Department at [email protected].

Supplemental Financial Information
The following table presents the components of our Insurance engine operating income.

Quarter Ended September 30,

Nine Months Ended
September 30,

Years Ended December 31,

(dollars in thousands)

Advertisement

2024

2023

2024

2023

2023

2022

2021

2020

Insurance operating income (loss):

Insurance segment

Advertisement

$  109,584

$       25,092

$  350,073

$     256,247

$  162,176

$  549,871

$  696,413

$  169,001

Reinsurance segment

(33,531)

Advertisement

(5,812)

(20,200)

33,606

(19,265)

83,859

(55,129)

(75,470)

Other insurance operations

69,220

50,590

Advertisement

128,150

154,718

205,234

294,979

77,516

43,454

Insurance

$  145,273

$       69,870

$  458,023

Advertisement

$     444,571

$  348,145

$  928,709

$  718,800

$  136,985

 

Non-GAAP Financial Measures
Consolidated segment operating income is a non-GAAP financial measure as it represents the total of the segment operating income from each of our operating segments and excludes items included in operating income. Consolidated segment operating income excludes amortization of acquired intangible assets and goodwill impairments arising from purchase accounting as they do not represent costs of operating the underlying businesses. The following table reconciles operating income to consolidated segment operating income.

Quarter Ended September 30,

Nine Months Ended
September 30,

Years Ended December 31,

Advertisement

(dollars in thousands)

2024

2023

2024

2023

2023

2022

2021

2020

Operating income (loss)

Advertisement

$  1,371,326

$     72,810

$  3,117,092

$  1,796,770

$  2,928,828

$    (93,336)

$  3,241,505

$  1,273,884

Amortization of acquired
intangible assets

46,459

Advertisement

47,545

134,981

136,367

180,614

178,778

160,539

159,315

Impairment of goodwill

Advertisement

80,000

Consolidated segment
operating income

$  1,417,785

$   120,355

$  3,252,073

Advertisement

$  1,933,137

$  3,109,442

$   165,442

$  3,402,044

$  1,433,199

 

About Markel Group
Markel Group Inc. is a diverse family of companies that includes everything from insurance to bakery equipment, building supplies, houseplants, and more. The leadership teams of these businesses operate with a high degree of independence, while at the same time living the values that we call the Markel Style. Our specialty insurance business sits at the core of our company. Through decades of sound underwriting, the insurance team has provided the capital base from which we built a system of businesses and investments that collectively increase Markel Group’s durability and adaptability. It’s a system that provides diverse income streams, access to a wide range of investment opportunities, and the ability to efficiently move capital to the best ideas across the company. Most importantly though, this system enables each of our businesses to advance our shared goal of helping our customers, associates, and shareholders win over the long term. Visit mklgroup.com to learn more.

Cautionary Statement
Certain of the statements in this release may be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Statements that are not historical facts, including statements about our beliefs, plans or expectations, are forward-looking statements. These statements are based on our current plans, estimates and expectations. There are risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by such statements. Factors that may cause actual results to differ are often presented with the forward-looking statements themselves. Additional factors that could cause actual results to differ from those predicted are set forth in our Annual Report on Form 10-K for the year ended December 31, 2023, including under “Business Overview,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Safe Harbor and Cautionary Statement,” and “Quantitative and Qualitative Disclosures About Market Risk,” and in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, including under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Safe Harbor and Cautionary Statement,” and “Quantitative and Qualitative Disclosures About Market Risk”. We assume no obligation to update this release (including any forward-looking statements) as a result of new information, developments, or otherwise. This release speaks only as of the date issued.

Logo – https://mma.prnewswire.com/media/2077105/Markel_Group_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/markel-group-reports-2024-third-quarter-and-nine-months-results-302292112.html

Advertisement
Continue Reading

Fintech PR

Aker Solutions ASA: Proposed extraordinary cash dividend of NOK 21 per share, in total NOK 10 billion

Published

on

aker-solutions-asa:-proposed-extraordinary-cash-dividend-of-nok-21-per-share,-in-total-nok-10-billion

OSLO, Norway, Oct. 30, 2024 /PRNewswire/ — The Board of Directors of Aker Solutions ASA (“Aker Solutions”) has proposed to pay out an extraordinary cash dividend of NOK 21.00 per share, pending approval in an Extraordinary General Meeting (EGM) to be held on November 22, 2024.

  • Dividend amount: NOK 21.00 per share
  • Total dividend amount (excluding own shares): NOK 10 billion
  • Last day including right: 22 November 2024 
  • Ex-date: 25 November 2024 
  • Record date: 26 November 2024 
  • Payment date: 2 December 2024
  • Date of approval (EGM): 22 November 2024 

The Board of Directors of Aker Solutions has today resolved to propose paying an extraordinary dividend of NOK 21.00 per share. Aker Solutions has a total of 492 167 089 outstanding shares, of which 13 708 424 shares are held by Aker Solutions at the date hereof. Own shares will not be entitled to the dividend. The proposed extraordinary dividend is based on the approved annual accounts for 2023. Notice of the EGM will be distributed separately. 

“The extraordinary dividend proposed by the Board of Directors reflects the value creation in Aker Solutions over time. After the dividend payment, the company will maintain a solid balance sheet, enabling continued development of the company and its employees, in addition to creating solid shareholder returns”, said Leif-Arne Langøy, Chairman of the Board at Aker Solutions.

“I am proud of the fact that we are delivering on our ambitious targets and that we continue to serve our investors through an attractive capital allocation strategy”, said Kjetel Digre, Chief Executive Officer at Aker Solutions. 

CONTACT: 
Preben Ørbeck
investor relations
[email protected] 
+47 470 10 611

Hallvard Norum
media contact
[email protected] 
+47 913 80 820

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/aker-solutions-asa/r/aker-solutions-asa–proposed-extraordinary-cash-dividend-of-nok-21-per-share–in-total-nok-10-billio,c4059137

View original content:https://www.prnewswire.co.uk/news-releases/aker-solutions-asa-proposed-extraordinary-cash-dividend-of-nok-21-per-share-in-total-nok-10-billion-302292057.html

Continue Reading

Fintech PR

MilDef signs contracts with BAE Systems Hägglunds for IT equipment in CV90 deliveries to Central Europe worth MSEK 200

Published

on

mildef-signs-contracts-with-bae-systems-hagglunds-for-it-equipment-in-cv90-deliveries-to-central-europe-worth-msek-200

HELSINGBORG, Sweden, Oct. 30, 2024 /PRNewswire/ — MilDef has been entrusted with the delivery of rugged IT equipment for operator stations in newly manufactured CV90 combat vehicles, which BAE Systems Hägglunds will deliver to Armed Forces in Central Europe. The agreement is initially worth MSEK 200 and deliveries will take place in 2025-2029. Given the outcome from options, the total value can reach MSEK 280.

The orders now won are a natural continuation of a long-standing collaboration with BAE Systems Hägglunds in Örnsköldsvik and cover IT equipment for the toughest conditions and most challenging environments, which prevents information from being interrupted, intercepted or disrupted. MilDef’s delivery of robust IT equipment will contribute to the capability-enhancing digitization of the newly manufactured CV90s to be delivered to Central European NATO nations.

“We are proud to deliver capabilities to what is considered the world’s best combat vehicles. This trust is based on a combination of long-standing relationships, proven technology and co-created cutting-edge technology development. Together with BAE Systems Hägglunds, we demonstrate the technological excellence of the Nordic defense industrial system and the responsibility the companies take to strengthen European security of supply and defense capabilities,” says Daniel Ljunggren, President and CEO of MilDef.

The CV90 combat vehicle is a family of armored vehicles developed by BAE Systems Hägglunds in Örnsköldsvik. The CV90 has been selected by 10 nations and is a proven platform that has proven its combat capability in both Afghanistan and Ukraine.

The information was submitted for publication, through the agency of the contact persons set out below at 17:00 CET on October, 30, 2024. 

CONTACT: 
For more information, please contact:
Daniel Ljunggren, CEO and President
Phone: +46 70 668 00 15
Email: [email protected]

Olof Engvall, Head of IR & Communications
Phone: +46 735 41 45 73
Email: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mildef-group-ab/r/mildef-signs-contracts-with-bae-systems-hagglunds-for-it-equipment-in-cv90-deliveries-to-central-eur,c4058624

The following files are available for download:

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/mildef-signs-contracts-with-bae-systems-hagglunds-for-it-equipment-in-cv90-deliveries-to-central-europe-worth-msek-200-302292034.html

Continue Reading

Trending